Which hedge funds own INO? INOVIO PHARMACEUTICALS INC, Q2 2026 13F holders

13 tracked hedge funds disclosed a position in INO (INOVIO PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $12.1m in total. The largest holder by portfolio weight is Boxer Capital Management, LLC at 0.2% of its book. 2 opened a new position this quarter: Caption Management, LLC, Engineers Gate Manager LP. 8 exited: Diadema Partners LP, Persistent Asset Partners Ltd, 683 Capital Management, LLC.

13

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

2

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

8

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$564k

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$3.2m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$12.1m

Combined value

Sum of the holders' reported positions in the security.

1.0%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.